comparison with a pure analytical standard. The tissue distribution of quetiapine was as follows: heart blood present, but less than (+<) 0.10-49 mg/L (seven cases); femoral blood +< 0.10-1.4 mg/L (five cases); liver +< 0.10-112 mg/kg (five cases); spleen 4.0 mg/kg (one case); urine 0-3.0 mg/L (two cases); bile 0.60-7.5 mg/L (three cases); and gastric contents +< 0.01-18 mg total (five cases). To our knowledge, this is the first report of the presence of quetiapine in postmortem specimens.
Introduction
Quetiapine fumarate (Seroquel, 2-[2-(4-dibenzo [b,f] [1, 4] thiazepin-11-yl-l-piperazinyl)-ethoxyl]-ethanol furnarate, 2:1, salt) was developed in 1993 and approved by the U.S. Food and Drug Administration in September of 1997 for the use in managing the manifestations of psychotic disorders, including schizophrenia. Quetiapine belongs to a chemical class known as the dibenzothiazepine derivatives and has a molecular formula of C21H~sN:~O2S ( Figure 1 ) and a molecular weight of 383.6. Structurally, it is related to the antipsychotic drug clozapine (1) . Pharmacologically, quetiapine is an antagonist at the serotonin, dopamine, histamine, and andrenergic neurotransmitter receptor sites in the brain (2) .
Quetiapine is rapidly absorbed after oral administration, with peak plasma concentrations reached after 1.5 h. It is 83% plasma protein bound and widely distributed throughout the body, with a volume of distribution of 10 • 4 L/kg. Quetiapine is extensively metabolized in the liver, and elimination is primarily by hepatic metabolism with 73% excreted in the urine. Less than 1% is excreted as unchanged drug. Quetiapine has a mean terminal half-life of about 6 h, and steady-state concentrations are achieved within two days of dosing. Quetiapine is dispensed for oral administration as the fumarate salt in 25-, 100-, and 200-mg tablets (1, 2) . Daily doses in adults range from 150 to 750 mg (1).
Case Histories

Case #1
A 35-year-old female (height 68 in., weight ]65 kg) had an 8-year history of depression. The decedent had chronic shoulder pain and was upset over her recent job loss. Prior to being found unresponsive on the living room floor of her residence by police officers, she had called a suicide prevention hotline and was reported to have had thick, slurred speech while discussing her suicidal thoughts. The following medications had been prescribed to the decedent and were recovered at the scene: alprazolam 1.0 mg QID, amitriptyline 50 mg 2-QD pro, amitriptyline 100 rng 3-QD prn, propoxyphene 100 mg QID, temazepam 30 mg 2-QD prn, and quetiapine 100 mg TID for four days, then BID. The autopsy revealed cardiomegaly (dilated and flabby), obesity, and pulmonary congestion.
Case #2
A 40-year-old male (height 67 in., weight 93 kg) was found decomposed in a hotel room by a maid. He was diagnosed with /---k 
CH2CH2OCH2CH2OH
Journal o{ Analytical Toxicology, Vol. 24, May/June 2000 bipolar disorder and had been under the care of a psychiatrist for the previous 10 years. He was despondent over a recent arrest and had one previous suicide attempt. The decedent had been prescribed the following medications: alprazolam 2 rag, clonazepam 0.5 mg 1-QD pro, flurazepam 15 mg 1-2-QD pro, gabapentin 300 mg 1-BID, and quetiapine 100 mg 1-2-QD. Autopsy findings included early to moderate decomposition and congestion of the lungs.
of her residence and had vomitus on her face. A three-page suicide note, loose pills (fluphenazine and olanzapine), and empty containers of diazepam were found at scene. She had four prior suicide attempts by overdose. The following medications were prescribed to the decedent: diazepam 5 mg 1-2 QD, fluphenazine 0.5 mg, and olanzapine 2.5 mg. The autopsy findings included gastric material in the upper respiratory tract.
Case #3
A 34-year-old female (height 64 in., weight 77 kg) had Huntington's Chorea and a history of depression and was a paranoid schizophrenic. She was found unresponsive on the kitchen floor
Case #4
A 44-year-old female (height 65 in., weight 73 kg) had a history of bipolar disorder, schizophrenia, and previous suicide attempts. She was found in the desert unresponsive outside of her parked vehicle with numerous slash wounds to her wrists. The following prescription medications were recovered from the passenger seat of her vehicle: quetiapine 100 mg 2-QD pm, clonazepam 0.5 mg 2-BID, trazodone 100 mg ]-QD pro, gabapentin 300 mg 3-BID, and venlafaxine 2-BID. The autopsy findings were unremarkable.
Case #5
A 43-year-old female (height 63 in., weight 77 kg) had a history of depression and was under the care of a psychiatrist. The decedent had a 20-year history of abusing prescription medications because of her medical problems which included a ruptured disk in her back, an appendectomy, and the removal of her ulcerated colon. The decedent was prescribed high doses of medication as a result of her colostomy. She was found unresponsive on the floor of her home next to a wooden box containing 46 prescription medication bottles. The following medications were prescribed: bupropion 75 rag, clonazepam 1 mg, cyclobenzaprine 10 rag, gabapentin 400 rag, hydromorphone, methadone 10 mg, olanzapine 10 mg, phenytoin 100 mg, prochlorperazine 10 mg, quetiapine 100 rag, risperidone 1 rag, valproic acid 500 rag, venlafaxine 75 rag, and zolpidem 10 rag. Autopsy findings included pulmonary edema and congestion.
Case #6
A 27-year-old female (height 60 in., weight 45 kg) was found unresponsive in a secure hotel room with drug paraphernalia. Autopsy findings included generalized congestion and fatty liver.
Case #7
A 43-year-old female (height 66 in., weight 91 kg) had a history of mental illness, chronic alcohol abuse, and multiple suicide attempts by overdose. She was found unresponsive in her bedroom during a welfare check. The following medications were recovered from her residence: nefazodone, lorazepam, valproic acid, phenytoin, propoxyphene, verapamil, phentermine, and quetiapine. Autopsy findings included pulmonary edema and congestion, visceral congestion, and cardiomegaly with left ventricular hypertrophy. Figure 5 . GC-MS spectra of the two minor metabolites of quetiapine from a blood extraction.
Experi mental
Specimens
All specimens were collected at the time of autopsy. Heart blood samples were collected and preserved in sodium fluoride. Peripheral blood samples from the femoral vein were collected and preserved in sodium fluoride and potassium oxalate. All other autopsy specimens such as liver, spleen, urine, bile, and gastric contents were stored without preservative. Tissues (liver, spleen, and gastric contents) were homogenized in a blender undiluted; dry tissues were diluted (1:1, w/v) with distilled water. All biological specimens were stored at 4~
Materials
Quetiapine fumarate was received courtesy of Zeneca Pharmaceuticals Inc. (Wilmington, DE) and prepared as a 1.0 g/L stock solution in methanol. The internal standard, carbinoxamine, was purchased from McNeil Laboratory and was also prepared as a 1.0 g/L stock solution in methanol. All reagents were analytical grade and purchased from various vendors.
Extraction
To 2 mL of standard made in porcine blood, blood sample, or tissue homogenate were added 100 pL of internal standard, (carbinoxamine 15 rag/L), 2 rnL buffer (20% sodium carbonate), and 6 rnL of n-butylchloride. After rotation for 20 min and centrifugation, the organic layer was separated. Two milliliters of 0.10N hydrochloric acid was added to the organic layer, and the sample was vortex mixed for 20 s. Following centrifugation and aspiration of the organic layer to waste, the aqueous layer was washed with 4 mL 2-methylbutane by vortex mixing for 15 s. The organic layer was aspirated to waste. The aqueous layer was made alkaline with 1 mL 20% sodium carbonate buffer and extracted with 4 mL 2-methylbutane by vortex mixing for 20 s. The organic layer was evaporated to dryness, the residue reconstituted with 75 IA methanol, and subsequently transferred to autosampler vials for instrumental analysis. Natural 0.32-mm i.d., 0.32-1~m film thickness). The oven temperature was programmed at 140~ for 0.50 min, increased to 300~ at 10~ and held for 10.5 rain (total analysis time of 27 min). The injector temperature was 260~ and the detector temperatures were 300~ Figure 2 represents the GC-NPD tracing of a postmortem blood specimen extract containing quetiapine and its metabolite pattern. The chromatograms illustrate quetiapine ( Figure 2D ) appears to have one major metabolite ( Figure 2A ) and two minor metabolites (Figures 2B and 2C) . The three metabolites elute earlier than the parent drug.
Confirmation was achieved with a Hewlett-Packard model 5890 GC equipped with a 5970 mass selective detector (MSD) and 7673 autosampler. The MSD was operated in the electron impact ionization mode and a full-scan mass-to-charge ratio range of 40-450 amu. An HP-5 (15 m x 0.25-mm i.d., 0.25-pro film thickness) capillary column was used. The oven temperature was programmed at 10~ from 120~ to 300~ with a final hold for 2 rain (total analysis time of 20 min). The injection-and detection-port temperatures were 260~ and 300~ respectively. The mass spectrum of quetiapine ( Figure 3 
Results
Specimens from the seven cases were submitted for toxicological analysis. Heart blood samples were tested for volatiles by headspace GC, screened for drugs of abuse (cocaine, opiates, methamphetamine, phencyclidine, and barbiturates) by radioimmunoassay, and screened for therapeutic drugs by GC-NPD. Quetiapine was presumptively identified in the basic drug screen using GC-NPD and confirmed by GC-MS. Quantitation of quetiapine was performed with a second aliquot of specimen, extracted, and compared with standard quantities of quetiapine by GC-NPD. The assay was linear from 0.10 to 3.0 mg/L, and the limit of quantitation was established to be 0.10 mg/L. The limit of detection was not established. Postmortem concentrations of quetiapine, other drugs detected, and cause and manner of death for each of the seven cases are presented in Table I .
Discussion
The heart blood concentrations of the seven cases presented ranged from present, but less than (+<) 0.10 to 49 mg/L. In clinical trials, a single 75-mg oral dose of quetiapine produced a peak serum concentration averaging 0.28 mg/L (range, 0.14-0.37), and peak serum concentrations after a 450-rag oral dose averaged 0.40 mg/L (range, 0.19-0.63) (1) . Four of the seven cases had quetiapine levels above those cited for peak serum concentrations. Because femoral samples were not submitted for all cases, it is difficult to conclude whether quetiapine Journal of Analytical Toxicology, Vo[. 24, May/June 2000 exhibits postmortem distribution. However, by comparing the quetiapine concentrations in heart blood to femoral blood in case 3, 5.1 to 0.95 rag/L; case 4, 1.9 to 1.4 mg/L; and case 5, 0.43 to 0.26 mg/L, the data can be interpreted to suggest that quetiapine may exhibit postmortem redistribution. The large volume of distribution was demonstrated with the most abundant concentration of quetiapine found in the liver, +< 0.10-112 mg/kg, presumably a result of sequestering for metabolism. Other potential causes for increased postmortem liver concentrations include gastric diffusion and redistribution into the liver.
The literature cites two cases of quetiapine-involved drug intoxication. In the first case, a 26-year-old female with a history of paranoid schizophrenia and multiple attempts of suicide, allegedly ingested greater than 10 g of quetiapine. The serum level was measured at 12.7 mg/L. The patient was treated at the hospital, suffered no ill effects and was transferred to a psychiatric hospital (3) . A second case from the literature involved a 21-yearoold male with a history of schizoaffective disorder, who ingested 4700 mg of quetiapine and 600 mg of fluoxetine. A plasma level of quetiapine measured 0.18 mg/L, 60 h postingestion (4).
Although cases 1, 2, 3, and 4 had levels of quetiapine similar to those overdoses cited in the literature, quetiapine was not solely implicated as the cause of death. Case 5 had quetiapine levels consistent with those seen in clinical studies. Cases 6 and 7 had subtherapeutic concentrations of quetiapine. Because these levels were very low, the unique metabolite pattern assisted in the identification of quetiapine. In five of the seven cases, other drugs in large concentrations were determined; therefore, the cause of death was determined to be multiple drug intoxication. The mode of death in four of the seven cases was ruled suicide, two were accidental, and the other was determined to be a natural death.
